HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
$35.59
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$35.59
Sarado: Hun 13, 4:11:43 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$35.62
Sakop ng araw
$35.05 - $35.67
Sakop ng taon
$23.95 - $52.34
Market cap
5.66B USD
Average na Volume
1.52M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 131.61M | 10.14% |
Gastos sa pagpapatakbo | 83.55M | 39.85% |
Net na kita | -146.94M | -2.90% |
Net profit margin | -111.64 | 6.58% |
Kita sa bawat share | -0.92 | -20.52% |
EBITDA | -144.05M | 1.56% |
Aktuwal na % ng binabayarang buwis | -0.08% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.15B | -3.00% |
Kabuuang asset | 2.81B | 1.77% |
Kabuuang sagutin | 2.34B | -5.28% |
Kabuuang equity | 475.73M | — |
Natitirang share | 159.16M | — |
Presyo para makapag-book | 11.91 | — |
Return on assets | -12.62% | — |
Return on capital | -14.71% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -146.94M | -2.90% |
Cash mula sa mga operasyon | -150.78M | -0.56% |
Cash mula sa pag-invest | 170.46M | 123.98% |
Cash mula sa financing | 2.20M | -90.67% |
Net change in cash | 22.12M | 143.90% |
Malayang cash flow | -107.97M | -16.56% |
Tungkol
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Itinatag
1989
Headquarters
Website
Mga Empleyado
1,069
